Gastrointestinal Therapeutics Market to Reach $64.5 Billion, Globally, by 2032 | Bayer AG, AbbVie, Takeda Pharmaceutical
PORTLAND, IN, UNITED STATES, March 17, 2025 /EINPresswire.com/ -- According to the report, the global gastrointestinal therapeutics industry generated $39.5 billion in 2022, and is anticipated to generate $64.5 billion by 2032, witnessing a CAGR …